Skip to Main Content

Author Details

Raffaella Santoro
University of Zurich
1991
57
30
PMIDPaper TitleJournal TitlePublished Year
37230037Methods for mapping 3D-chromosome architecture around nucleoli.Curr Opin Cell Biol2023
37184661BAZ2A-RNA mediated association with TOP2A and KDM1A represses genes implicated in prostate cancer.Life Sci Alliance2023
37230037Methods for mapping 3D-chromosome architecture around nucleoli.Curr Opin Cell Biol2023
37184661BAZ2A-RNA mediated association with TOP2A and KDM1A represses genes implicated in prostate cancer.Life Sci Alliance2023
35304483Genome-wide maps of nucleolus interactions reveal distinct layers of repressive chromatin domains.Nat Commun2022
36447428Image analysis workflows to reveal the spatial organization of cell nuclei and chromosomes.Nucleus2022
35304483Genome-wide maps of nucleolus interactions reveal distinct layers of repressive chromatin domains.Nat Commun2022
36447428Image analysis workflows to reveal the spatial organization of cell nuclei and chromosomes.Nucleus2022
34417458Epigenetic control of melanoma cell invasiveness by the stem cell factor SALL4.Nat Commun2021
34403195BAZ2A-mediated repression via H3K14ac-marked enhancers promotes prostate cancer stem cells.EMBO Rep2021
34890550Looking for a job in a dynamic and collaborative working place? LncRNAs are recruiting!Cell2021
34417458Epigenetic control of melanoma cell invasiveness by the stem cell factor SALL4.Nat Commun2021
34890550Looking for a job in a dynamic and collaborative working place? LncRNAs are recruiting!Cell2021
34403195BAZ2A-mediated repression via H3K14ac-marked enhancers promotes prostate cancer stem cells.EMBO Rep2021
32976768Regulation and Roles of the Nucleolus in Embryonic Stem Cells: From Ribosome Biogenesis to Genome Organization.Stem Cell Reports2020
32024754TIP5 primes prostate luminal cells for the oncogenic transformation mediated by <i>PTEN</i>-loss.Proc Natl Acad Sci U S A2020
32976768Regulation and Roles of the Nucleolus in Embryonic Stem Cells: From Ribosome Biogenesis to Genome Organization.Stem Cell Reports2020
33433018BAZ2A safeguards genome architecture of ground-state pluripotent stem cells.EMBO J2020
32024754TIP5 primes prostate luminal cells for the oncogenic transformation mediated by <i>PTEN</i>-loss.Proc Natl Acad Sci U S A2020
33433018BAZ2A safeguards genome architecture of ground-state pluripotent stem cells.EMBO J2020
31212844Genome Organization in and around the Nucleolus.Cells2019
31212844Genome Organization in and around the Nucleolus.Cells2019
31327501Nucleolus and rRNA Gene Chromatin in Early Embryo Development.Trends Genet2019
31327501Nucleolus and rRNA Gene Chromatin in Early Embryo Development.Trends Genet2019
30333056Oxidative stress in sperm affects the epigenetic reprogramming in early embryonic development.Epigenetics Chromatin2018
30008323EZH2-Mediated Primary Cilium Deconstruction Drives Metastatic Melanoma Formation.Cancer Cell2018
30333056Oxidative stress in sperm affects the epigenetic reprogramming in early embryonic development.Epigenetics Chromatin2018
30008323EZH2-Mediated Primary Cilium Deconstruction Drives Metastatic Melanoma Formation.Cancer Cell2018
28604677Pramel7 mediates ground-state pluripotency through proteasomal-epigenetic combined pathways.Nat Cell Biol2017
28604677Pramel7 mediates ground-state pluripotency through proteasomal-epigenetic combined pathways.Nat Cell Biol2017
28466247Is trace element concentration correlated to parasite abundance? A case study in a population of the green frog Pelophylax synkl. hispanicus from the Neto River (Calabria, southern Italy).Parasitol Res2017
28588071The RNA helicase DHX9 establishes nucleolar heterochromatin, and this activity is required for embryonic stem cell differentiation.EMBO Rep2017
28752849Corrigendum: Pramel7 mediates ground-state pluripotency through proteasomal-epigenetic combined pathways.Nat Cell Biol2017
28466247Is trace element concentration correlated to parasite abundance? A case study in a population of the green frog Pelophylax synkl. hispanicus from the Neto River (Calabria, southern Italy).Parasitol Res2017
28752849Corrigendum: Pramel7 mediates ground-state pluripotency through proteasomal-epigenetic combined pathways.Nat Cell Biol2017
28588071The RNA helicase DHX9 establishes nucleolar heterochromatin, and this activity is required for embryonic stem cell differentiation.EMBO Rep2017
26848772Identification of cis- and trans-acting elements regulating calretinin expression in mesothelioma cells.Oncotarget2016
26848772Identification of cis- and trans-acting elements regulating calretinin expression in mesothelioma cells.Oncotarget2016
27417130Challenges in the analysis of long noncoding RNA functionality.FEBS Lett2016
27760049Helicase CHD4 is an epigenetic coregulator of PAX3-FOXO1 in alveolar rhabdomyosarcoma.J Clin Invest2016
27760049Helicase CHD4 is an epigenetic coregulator of PAX3-FOXO1 in alveolar rhabdomyosarcoma.J Clin Invest2016
27417130Challenges in the analysis of long noncoding RNA functionality.FEBS Lett2016
25609585The epigenetic modifier EZH2 controls melanoma growth and metastasis through silencing of distinct tumour suppressors.Nat Commun2015
25885555Methylation-dependent SOX9 expression mediates invasion in human melanoma cells and is a negative prognostic factor in advanced melanoma.Genome Biol2015
25629959Antagonistic cross-regulation between Sox9 and Sox10 controls an anti-tumorigenic program in melanoma.PLoS Genet2015
25485837BAZ2A (TIP5) is involved in epigenetic alterations in prostate cancer and its overexpression predicts disease recurrence.Nat Genet2015
25609585The epigenetic modifier EZH2 controls melanoma growth and metastasis through silencing of distinct tumour suppressors.Nat Commun2015
25885555Methylation-dependent SOX9 expression mediates invasion in human melanoma cells and is a negative prognostic factor in advanced melanoma.Genome Biol2015
25629959Antagonistic cross-regulation between Sox9 and Sox10 controls an anti-tumorigenic program in melanoma.PLoS Genet2015
25485837BAZ2A (TIP5) is involved in epigenetic alterations in prostate cancer and its overexpression predicts disease recurrence.Nat Genet2015
  • 1 - 50 of 114

Recommended Authors

Aishe A Sarshad
Institute of Biomedicine, University of Gothenburg
Career Start Year 2013
Number of shared co-authors 0
Greg Donahue
Penn Epigenetics Institute, Perelman School of Medicine, University of Pennsylvania
Career Start Year 2010
Number of shared co-authors 0
Maud de Dieuleveult
ULB-Cancer Research Centre (U-CRC), Universite Libre De Bruxelles
Career Start Year 2008
Number of shared co-authors 0
Yue Lu
The University of Texas MD Anderson Cancer Center
Career Start Year 2006
Number of shared co-authors 0
J Peter Svensson
Karolinska Institutet
Career Start Year 2005
Number of shared co-authors 0
Guillaume J Filion
University of Toronto Scarborough
Career Start Year 2004
Number of shared co-authors 0
Ho-Ryun Chung
Institute of Medical Bioinformatics and Biostatistics, Philipps University of Marburg
Career Start Year 2002
Number of shared co-authors 1
Michael J Buck
Jacobs School of Medicine and Biomedical Sciences, University at Buffalo
Career Start Year 2002
Number of shared co-authors 0
Nicolas Lacoste
Institut NeuroMyoGene, Universite Lyon1-CNRS UMR1-INSERM U1315
Career Start Year 2001
Number of shared co-authors 0
Michael Y Tolstorukov
Dana-Farber Cancer Institute
Career Start Year 2000
Number of shared co-authors 0
Yoichiro Shibata
Center for Genomic and Computational Biology, Duke University.
Career Start Year 2000
Number of shared co-authors 0
Siavash K Kurdistani
David Geffen School of Medicine, University of California los angeles
Career Start Year 1998
Number of shared co-authors 0
Zhiguo Zhang
Institute for Cancer Genetics, Columbia University Irving Medical Center
Career Start Year 1997
Number of shared co-authors 0
Jason D Lieb
The University of Chicago
Career Start Year 1996
Number of shared co-authors 2
Fran??ois Robert
Institut de recherches cliniques de Montreal
Career Start Year 1996
Number of shared co-authors 0
Brian D Strahl
University of North Carolina
Career Start Year 1996
Number of shared co-authors 0
Bing Ren
Center for Epigenomics, University of California San Diego
Career Start Year 1995
Number of shared co-authors 2
Colin Logie
Radboud Institute for Molecular Science, Radboud University
Career Start Year 1995
Number of shared co-authors 1
Bradley E Bernstein
Broad Institute of MIT and Harvard
Career Start Year 1994
Number of shared co-authors 1
Ana Pombo
Polytechnic Institute of Leiria
Career Start Year 1994
Number of shared co-authors 1
Oliver J Rando
University of Massachusetts Chan Medical School
Career Start Year 1994
Number of shared co-authors 0
Jennifer L Gerton
Stowers Institute for Medical Research
Career Start Year 1992
Number of shared co-authors 0
Karl Ekwall
Karolinska Institute
Career Start Year 1991
Number of shared co-authors 1
Bas van Steensel
Oncode Institute, Netherlands Cancer Institute
Career Start Year 1991
Number of shared co-authors 0
Ali Shilatifard
Northwestern University Feinberg School of Medicine
Career Start Year 1991
Number of shared co-authors 1
Jacques C??t??
Centre Hospitalier Universitaire (CHU) de Quebec-Universite Laval Research Center
Career Start Year 1987
Number of shared co-authors 0
Shelley L Berger
Penn Epigenetics Institute, Perelman School of Medicine
Career Start Year 1985
Number of shared co-authors 2
Danny Reinberg
HHMI/NYU Langone School of Medicine
Career Start Year 1980
Number of shared co-authors 1
C David Allis
The Rockefeller University
Career Start Year 1974
Number of shared co-authors 0
Steven Henikoff
Fred Hutchinson Cancer Center
Career Start Year 1974
Number of shared co-authors 0

Collaborators

Reinhard Dummer
University Hospital Zurich
Co-authored papers 5
Mitchell P Levesque
University Hospital Zurich
Co-authored papers 5
Phil F Cheng
University Hospital of Zurich
Co-authored papers 5
Lukas Sommer
Institute of Anatomy, University of Zurich
Co-authored papers 5
Paolo Cinelli
Zurich University Hospital
Co-authored papers 4
Olga Shakhova
Institute of Anatomy, University of Zurich
Co-authored papers 4
Daniel Zingg
Netherlands Cancer Institute
Co-authored papers 4
Simon M Schaefer
Institute of Anatomy, University of Zurich
Co-authored papers 3
Julien Debbache
Institute of Anatomy, University of Zurich
Co-authored papers 3
Haruhiko Koseki
RIKEN Research Center for Allergy and Immunology
Co-authored papers 2
Jessica H??usel
University Hospital Basel, University of Basel
Co-authored papers 2
Ronald Simon
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Co-authored papers 2
Guido Sauter
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Co-authored papers 2
Holger Moch
University Hospital Zurich
Co-authored papers 1
Carlos L??pez-Ot??n
Instituto Universitario de Oncologia, Universidad de Oviedo
Co-authored papers 1
Marie-Laure Yaspo
Max Planck Institute for Molecular Genetics
Co-authored papers 1
Theresa Guo
Moores Cancer Center, University of California
Co-authored papers 1
Daniela Mihic-Probst
University Hospital Zurich
Co-authored papers 1
Beat W Sch??fer
Department of Oncology and Children's Research Center, University Children's Hospital
Co-authored papers 1
Ana C Marques
University of Lausanne
Co-authored papers 1
Brock C Christensen
Geisel School of Medicine, Dartmouth College
Co-authored papers 1
Jan O Korbel
European Bioinformatics Institute (EMBL-EBI)
Co-authored papers 1
Paolo Nanni
Functional Genomics Center Zurich (FGCZ)-University of Zurich/ETH Zurich
Co-authored papers 1
Glenn Merlino
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 1
Benedikt Brors
German Cancer Research Center (DKFZ)
Co-authored papers 1
Claudia Matter
University Hospital Zurich, University of Zurich
Co-authored papers 1
Lorenz Studer
The Center for Stem Cell Biology, Memorial Sloan Kettering Cancer Center
Co-authored papers 1
Holger S??ltmann
German Cancer Research Center (DKFZ)
Co-authored papers 1
Xose S Puente
University of Oviedo
Co-authored papers 1
Susan R Davis
Co-authored papers 1
Release 1.2